- Home
- RAMP vs CNTA Comparison
RAMP vs CNTA Comparison
Compare RAMP & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAMP
- CNTA
- Stock Information
- Founded
- RAMP 2018
- CNTA 2020
- Country
- RAMP United States
- CNTA United Kingdom
- Employees
- RAMP N/A
- CNTA N/A
- Industry
- RAMP EDP Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- RAMP Technology
- CNTA Health Care
- Exchange
- RAMP Nasdaq
- CNTA Nasdaq
- Market Cap
- RAMP 2.2B
- CNTA 1.8B
- IPO Year
- RAMP 1987
- CNTA 2021
- Fundamental
- Price
- RAMP $28.18
- CNTA $12.30
- Analyst Decision
- RAMP Buy
- CNTA Strong Buy
- Analyst Count
- RAMP 6
- CNTA 10
- Target Price
- RAMP $38.17
- CNTA $26.11
- AVG Volume (30 Days)
- RAMP 499.0K
- CNTA 617.5K
- Earning Date
- RAMP 05-21-2025
- CNTA 05-20-2025
- Dividend Yield
- RAMP N/A
- CNTA N/A
- EPS Growth
- RAMP N/A
- CNTA N/A
- EPS
- RAMP 0.00
- CNTA N/A
- Revenue
- RAMP $728,708,000.00
- CNTA N/A
- Revenue This Year
- RAMP $14.81
- CNTA N/A
- Revenue Next Year
- RAMP $7.62
- CNTA N/A
- P/E Ratio
- RAMP $23,127.21
- CNTA N/A
- Revenue Growth
- RAMP 14.50
- CNTA N/A
- 52 Week Low
- RAMP $21.45
- CNTA $7.75
- 52 Week High
- RAMP $38.00
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- RAMP 62.65
- CNTA 40.97
- Support Level
- RAMP $26.07
- CNTA $11.88
- Resistance Level
- RAMP $27.41
- CNTA $14.39
- Average True Range (ATR)
- RAMP 0.66
- CNTA 0.79
- MACD
- RAMP 0.30
- CNTA -0.00
- Stochastic Oscillator
- RAMP 92.95
- CNTA 18.68
About RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.